In our study, we showed that estrogen suppressed production of IL-6 and subsequently reduced W4P-induced tumor growth in male mice, which suggests that a high level of estrogen in female mice suppresses tumorigenesis by W4P variant HBV through regulating IL-6 signaling. Here, IL6 is linked to neoplasm.